Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 · Annals of Oncology · 1,598 citations
https://doi.org/10.1093/annonc/mdy096
H
Hans Gelderblom
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.3K
Papers
53.3K
Citations
107
h-index
582
i10-index
Hans Gelderblom is an academic researcher from Leiden University Medical Center. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Gastrointestinal Tumor Research and Treatment & Colorectal Cancer Treatments and Studies. The author has an h-index of 107, co-authored 1117 publications.
ORCID: 0000-0001-9270-8636Papers by this author
worksEfficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 · The Lancet · 1,392 citations
https://doi.org/10.1016/s0140-6736(12)61857-1
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
2012 · New England Journal of Medicine · 845 citations
https://doi.org/10.1056/nejmoa1200966
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 · Annals of Oncology · 716 citations
https://doi.org/10.1093/annonc/mdq223
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
2019 · European Journal of Cancer · 700 citations
https://doi.org/10.1016/j.ejca.2018.11.027
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 · Annals of Oncology · 623 citations
https://doi.org/10.1093/annonc/mdy310
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat